| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tubulin binding | 1.83e-05 | 428 | 54 | 8 | GO:0015631 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | EEF2 CCDC88A KIF3B BRCA2 MYH7B PAFAH1B1 KIF16B LSP1 RP1 GNAS NIN | 1.44e-04 | 1099 | 54 | 11 | GO:0008092 |
| GeneOntologyMolecularFunction | microtubule binding | 1.78e-04 | 308 | 54 | 6 | GO:0008017 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 4.68e-04 | 56 | 54 | 3 | GO:0030170 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 4.93e-04 | 57 | 54 | 3 | GO:0070279 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 9.51e-04 | 17 | 54 | 2 | GO:0008574 | |
| GeneOntologyMolecularFunction | dynein heavy chain binding | 9.51e-04 | 17 | 54 | 2 | GO:0045504 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.06e-03 | 775 | 54 | 8 | GO:0017111 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.27e-03 | 614 | 54 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.76e-03 | 839 | 54 | 8 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.77e-03 | 840 | 54 | 8 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.77e-03 | 840 | 54 | 8 | GO:0016818 | |
| GeneOntologyMolecularFunction | dynein complex binding | 2.59e-03 | 28 | 54 | 2 | GO:0070840 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CDKN1B IQCA1L CCDC88A KIF3B BRCA2 CNTRL PAFAH1B1 DNAI4 RP1 DYNC1LI2 NIN | 2.56e-06 | 720 | 55 | 11 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | CDKN1B IQCA1L CCDC88A KIF3B BRCA2 CNTRL PAFAH1B1 KIF16B DNAI4 RP1 DYNC1LI2 NIN | 1.76e-05 | 1058 | 55 | 12 | GO:0007017 |
| GeneOntologyBiologicalProcess | cilium assembly | 2.17e-05 | 444 | 55 | 8 | GO:0060271 | |
| GeneOntologyBiologicalProcess | cilium organization | 3.57e-05 | 476 | 55 | 8 | GO:0044782 | |
| GeneOntologyBiologicalProcess | centrosome localization | 1.11e-04 | 35 | 55 | 3 | GO:0051642 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 1.20e-04 | 36 | 55 | 3 | GO:0061842 | |
| GeneOntologyBiologicalProcess | corpus callosum morphogenesis | 1.93e-04 | 8 | 55 | 2 | GO:0021540 | |
| GeneOntologyCellularComponent | spindle | WAPL ZZZ3 KIF3B CEP162 CNTRL PAFAH1B1 KIF16B CDC25B TAF1D NIN | 3.62e-07 | 471 | 55 | 10 | GO:0005819 |
| GeneOntologyCellularComponent | microtubule organizing center | NEK1 CCDC88A KIF3B BRCA2 CEP162 CNTRL PAFAH1B1 C11orf97 CDC25B DYNC1LI2 TAF1D NIN | 3.71e-06 | 919 | 55 | 12 | GO:0005815 |
| GeneOntologyCellularComponent | microtubule associated complex | 4.03e-06 | 161 | 55 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | centrosome | NEK1 CCDC88A KIF3B BRCA2 CEP162 CNTRL PAFAH1B1 CDC25B DYNC1LI2 TAF1D NIN | 4.29e-06 | 770 | 55 | 11 | GO:0005813 |
| GeneOntologyCellularComponent | COPI-coated Golgi to ER transport vesicle | 6.80e-06 | 2 | 55 | 2 | GO:0030142 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.80e-04 | 317 | 55 | 6 | GO:0032838 | |
| GeneOntologyCellularComponent | mitotic spindle | 1.84e-04 | 201 | 55 | 5 | GO:0072686 | |
| GeneOntologyCellularComponent | kinesin complex | 2.91e-04 | 49 | 55 | 3 | GO:0005871 | |
| GeneOntologyCellularComponent | centriolar subdistal appendage | 3.02e-04 | 10 | 55 | 2 | GO:0120103 | |
| GeneOntologyCellularComponent | cytoplasmic region | 3.56e-04 | 360 | 55 | 6 | GO:0099568 | |
| GeneOntologyCellularComponent | centriolar satellite | 3.59e-04 | 128 | 55 | 4 | GO:0034451 | |
| GeneOntologyCellularComponent | microtubule | 4.74e-04 | 533 | 55 | 7 | GO:0005874 | |
| GeneOntologyCellularComponent | cilium | 5.14e-04 | 898 | 55 | 9 | GO:0005929 | |
| GeneOntologyCellularComponent | axoneme | 2.15e-03 | 207 | 55 | 4 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 2.18e-03 | 208 | 55 | 4 | GO:0097014 | |
| GeneOntologyCellularComponent | pericentriolar material | 2.46e-03 | 28 | 55 | 2 | GO:0000242 | |
| GeneOntologyCellularComponent | COPI-coated vesicle | 3.41e-03 | 33 | 55 | 2 | GO:0030137 | |
| GeneOntologyCellularComponent | chromosomal region | 4.93e-03 | 421 | 55 | 5 | GO:0098687 | |
| GeneOntologyCellularComponent | aggresome | 4.97e-03 | 40 | 55 | 2 | GO:0016235 | |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 5.19e-03 | 133 | 55 | 3 | GO:0005881 | |
| Domain | - | 1.25e-04 | 35 | 52 | 3 | 3.90.1150.10 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 1.36e-04 | 36 | 52 | 3 | IPR015422 | |
| Domain | - | 1.73e-04 | 39 | 52 | 3 | 3.40.640.10 | |
| Domain | PyrdxlP-dep_Trfase | 2.01e-04 | 41 | 52 | 3 | IPR015424 | |
| Domain | PyrdxlP-dep_Trfase_major_sub1 | 2.01e-04 | 41 | 52 | 3 | IPR015421 | |
| Domain | Aminotransferase_I/II | 1.01e-03 | 17 | 52 | 2 | IPR004839 | |
| Domain | Aminotran_1_2 | 1.01e-03 | 17 | 52 | 2 | PF00155 | |
| Domain | C2H2_Znf_fam | 2.02e-03 | 24 | 52 | 2 | IPR027775 | |
| Domain | P-loop_NTPase | 2.23e-03 | 848 | 52 | 8 | IPR027417 | |
| Domain | Kinesin_motor_CS | 5.82e-03 | 41 | 52 | 2 | IPR019821 | |
| Domain | Kinesin-like_fam | 6.38e-03 | 43 | 52 | 2 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 6.67e-03 | 44 | 52 | 2 | PS00411 | |
| Domain | - | 6.67e-03 | 44 | 52 | 2 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 6.67e-03 | 44 | 52 | 2 | IPR001752 | |
| Domain | Kinesin | 6.67e-03 | 44 | 52 | 2 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 6.67e-03 | 44 | 52 | 2 | PS50067 | |
| Domain | KISc | 6.67e-03 | 44 | 52 | 2 | SM00129 | |
| Pathway | REACTOME_CELL_CYCLE | CDKN1B WAPL NUP107 BRCA2 CNTRL PAFAH1B1 RSF1 CDC25B MDM4 DYNC1LI2 | 3.43e-05 | 694 | 43 | 10 | M543 |
| Pubmed | 1.50e-07 | 146 | 57 | 6 | 21399614 | ||
| Pubmed | EEF2 CCDC88A BBX NUP107 CEP162 CNTRL SAR1B HUWE1 SLC39A10 DYNC1LI2 | 4.89e-07 | 777 | 57 | 10 | 35844135 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 11956314 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 5.08e-06 | 588 | 57 | 8 | 38580884 | |
| Pubmed | 5.18e-06 | 69 | 57 | 4 | 32238831 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 29024247 | ||
| Pubmed | Siah1/SIP regulates p27(kip1) stability and cell migration under metabolic stress. | 7.91e-06 | 3 | 57 | 2 | 21734459 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 18543099 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 27760328 | ||
| Pubmed | MDM4 is a rational target for treating breast cancers with mutant p53. | 7.91e-06 | 3 | 57 | 2 | 28097652 | |
| Pubmed | Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. | 1.58e-05 | 4 | 57 | 2 | 19656774 | |
| Pubmed | The kinetochore protein, CENPF, is mutated in human ciliopathy and microcephaly phenotypes. | 1.58e-05 | 4 | 57 | 2 | 25564561 | |
| Pubmed | GIV/Girdin activates Gαi and inhibits Gαs via the same motif. | 1.58e-05 | 4 | 57 | 2 | 27621449 | |
| Pubmed | EEF2 KIF3B NUP107 CNTRL DOCK10 GOLIM4 LSP1 GNAS HUWE1 DYNC1LI2 | 1.81e-05 | 1168 | 57 | 10 | 19946888 | |
| Pubmed | 2.64e-05 | 104 | 57 | 4 | 9205841 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 16951165 | ||
| Pubmed | 6.02e-05 | 253 | 57 | 5 | 29911972 | ||
| Pubmed | 6.29e-05 | 418 | 57 | 6 | 34709266 | ||
| Pubmed | 3D-structured illumination microscopy provides novel insight into architecture of human centrosomes. | 7.34e-05 | 8 | 57 | 2 | 23213374 | |
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 9.14e-05 | 143 | 57 | 4 | 30397336 | |
| Pubmed | 1.18e-04 | 10 | 57 | 2 | 25220058 | ||
| Pubmed | 1.18e-04 | 10 | 57 | 2 | 20484223 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | EEF2 NUP107 PAFAH1B1 RSF1 GOLIM4 GNAS SLC39A10 ZNF518A ZNF646 | 1.39e-04 | 1203 | 57 | 9 | 29180619 |
| Pubmed | 1.86e-04 | 67 | 57 | 3 | 29357390 | ||
| Pubmed | The DNA sequence and comparative analysis of human chromosome 20. | 2.00e-04 | 517 | 57 | 6 | 11780052 | |
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 29285303 | ||
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 28416489 | ||
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 2.03e-04 | 13 | 57 | 2 | 17920017 | |
| Pubmed | 2.26e-04 | 529 | 57 | 6 | 14621295 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | NEK1 CCDC88A BBX KIF3B NUP107 PAFAH1B1 CDC25B DYNC1LI2 DHX30 | 2.79e-04 | 1321 | 57 | 9 | 27173435 |
| Pubmed | 2.97e-04 | 1049 | 57 | 8 | 27880917 | ||
| Pubmed | Proteomic analysis identifies novel binding partners of BAP1. | 3.14e-04 | 80 | 57 | 3 | 34591877 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 3.32e-04 | 1353 | 57 | 9 | 29467282 | |
| Pubmed | 3.37e-04 | 201 | 57 | 4 | 25192599 | ||
| Pubmed | Evidence for distinct functions for human DNA repair factors hHR23A and hHR23B. | 3.97e-04 | 18 | 57 | 2 | 16712842 | |
| Pubmed | 4.49e-04 | 1116 | 57 | 8 | 31753913 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 5.01e-04 | 861 | 57 | 7 | 36931259 | |
| Pubmed | 5.19e-04 | 95 | 57 | 3 | 24029230 | ||
| Pubmed | Genome-wide association studies identify four ER negative-specific breast cancer risk loci. | 5.43e-04 | 21 | 57 | 2 | 23535733 | |
| Pubmed | 5.43e-04 | 21 | 57 | 2 | 19686682 | ||
| Pubmed | 5.43e-04 | 21 | 57 | 2 | 24821722 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 5.63e-04 | 1155 | 57 | 8 | 20360068 | |
| Pubmed | 6.21e-04 | 101 | 57 | 3 | 10997877 | ||
| Pubmed | Centrosome-related genes, genetic variation, and risk of breast cancer. | 6.39e-04 | 102 | 57 | 3 | 20508983 | |
| Pubmed | 6.46e-04 | 645 | 57 | 6 | 25281560 | ||
| Pubmed | 6.73e-04 | 650 | 57 | 6 | 38777146 | ||
| Pubmed | 7.12e-04 | 24 | 57 | 2 | 24347629 | ||
| Pubmed | CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system. | 7.73e-04 | 440 | 57 | 5 | 35156780 | |
| Pubmed | Identification and classification of 16 new kinesin superfamily (KIF) proteins in mouse genome. | 7.73e-04 | 25 | 57 | 2 | 9275178 | |
| Pubmed | 7.75e-04 | 251 | 57 | 4 | 29778605 | ||
| Pubmed | O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma. | 8.10e-04 | 254 | 57 | 4 | 36604567 | |
| Pubmed | Epidermal development requires ninein for spindle orientation and cortical microtubule organization. | 8.36e-04 | 26 | 57 | 2 | 30923192 | |
| Pubmed | The antiobesity factor WDTC1 suppresses adipogenesis via the CRL4WDTC1 E3 ligase. | 8.80e-04 | 453 | 57 | 5 | 27113764 | |
| Pubmed | 9.10e-04 | 689 | 57 | 6 | 36543142 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 9.16e-04 | 954 | 57 | 7 | 36373674 | |
| Pubmed | 1.11e-03 | 30 | 57 | 2 | 33854235 | ||
| Pubmed | TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer. | 1.11e-03 | 30 | 57 | 2 | 34285210 | |
| Pubmed | A catalogue of putative HIV-1 protease host cell substrates. | 1.12e-03 | 124 | 57 | 3 | 22944692 | |
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 1.15e-03 | 125 | 57 | 3 | 21654808 | |
| Pubmed | 1.29e-03 | 288 | 57 | 4 | 23383273 | ||
| Pubmed | 1.40e-03 | 503 | 57 | 5 | 16964243 | ||
| Pubmed | Nuclear pore composition regulates neural stem/progenitor cell differentiation in the mouse embryo. | 1.43e-03 | 34 | 57 | 2 | 18539113 | |
| Pubmed | Lis1 mediates planar polarity of auditory hair cells through regulation of microtubule organization. | 1.43e-03 | 34 | 57 | 2 | 23533177 | |
| Pubmed | 1.52e-03 | 35 | 57 | 2 | 28106071 | ||
| Pubmed | 1.53e-03 | 513 | 57 | 5 | 25798074 | ||
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 1.56e-03 | 139 | 57 | 3 | 25476789 | |
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | 1.56e-03 | 516 | 57 | 5 | 36610398 | |
| Pubmed | Gene expression in pharyngeal arch 1 during human embryonic development. | 1.60e-03 | 36 | 57 | 2 | 15703188 | |
| Interaction | CDK1 interactions | CDKN1B BRCA2 ARID4A SAR1B PAFAH1B1 RSF1 HUWE1 CDC25B MDM4 MSI2 | 3.21e-06 | 590 | 54 | 10 | int:CDK1 |
| Interaction | CCNB1 interactions | 3.82e-06 | 244 | 54 | 7 | int:CCNB1 | |
| Cytoband | 11q21 | 1.39e-03 | 44 | 57 | 2 | 11q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p31 | 2.76e-03 | 224 | 57 | 3 | chr1p31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q21 | 2.82e-03 | 63 | 57 | 2 | chr11q21 | |
| Cytoband | 1p31.1 | 3.56e-03 | 71 | 57 | 2 | 1p31.1 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CDKN1B WAPL CCDC88A BBX ARID4A CNTRL PAFAH1B1 RSF1 DOCK10 LSP1 GNAS HUWE1 MDM4 NIN | 2.69e-06 | 1492 | 57 | 14 | M40023 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 4.67e-06 | 199 | 57 | 6 | M5893 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 1.12e-05 | 656 | 57 | 9 | M18979 | |
| Coexpression | GOLDRATH_HOMEOSTATIC_PROLIFERATION | 1.89e-05 | 150 | 57 | 5 | M3592 | |
| Coexpression | GOLDRATH_HOMEOSTATIC_PROLIFERATION | 2.36e-05 | 157 | 57 | 5 | MM613 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 3.86e-05 | 289 | 57 | 6 | M2196 | |
| Coexpression | GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN | 7.12e-05 | 198 | 57 | 5 | M7708 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP | 7.29e-05 | 199 | 57 | 5 | M6443 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 7.33e-05 | 474 | 57 | 7 | M40991 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 7.46e-05 | 200 | 57 | 5 | M5901 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 8.93e-05 | 856 | 57 | 9 | M4500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CDKN1B CCDC88A BRCA2 ARID4A CEP162 TLL1 CNTRL RSF1 CDC25B DHX30 TAF1D MSI2 SOS2 | 2.91e-05 | 1370 | 54 | 13 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | WAPL CCDC88A BRCA2 ARID4A TLL1 CNTRL RSF1 SLC39A10 ZNF518A DHX30 TAF1D MSI2 | 5.71e-05 | 1252 | 54 | 12 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.35e-04 | 311 | 54 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.40e-04 | 780 | 54 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.77e-04 | 469 | 54 | 7 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_200 | 2.18e-04 | 46 | 54 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.25e-04 | 831 | 54 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.37e-04 | 492 | 54 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.97e-07 | 197 | 57 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-06 | 185 | 57 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_only / Treatment groups by lineage, cell group, cell type | 5.46e-06 | 198 | 57 | 5 | 53c22e81e530d6fc272d4a45c8d1bf125feb254d | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.59e-06 | 199 | 57 | 5 | 82759af613ebfffe037afda55159bf6af812c3ac | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 5.59e-06 | 199 | 57 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 148 | 57 | 4 | 12fa2c4922f03803006c606b1b16e79441e3bb13 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.98e-05 | 149 | 57 | 4 | 54c9c6282f5f5de43dfaf2972fab3e3dcf9838a3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.98e-05 | 149 | 57 | 4 | 14d2e8cab97108d8fa94e540c1957b73ed32dc73 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.13e-05 | 159 | 57 | 4 | 807ee55fe0d3645fbfb98f641dd0a0555b847cf5 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.78e-05 | 164 | 57 | 4 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.20e-05 | 167 | 57 | 4 | fd84a99ea142d1684cdcf4a88ef1d541760bc78a | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.65e-05 | 170 | 57 | 4 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.60e-05 | 176 | 57 | 4 | 5f8c1f917fba49f3b1c0d88b946eca242b668fde | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-05 | 176 | 57 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | wk_15-18-Hematologic-Myeloid-aDC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.77e-05 | 177 | 57 | 4 | ccf5dc54780d6039a4d062dee88440c011ddc0a3 | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 182 | 57 | 4 | 0f06309318c064f0ebdb12a46226b90032290137 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 182 | 57 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 8.84e-05 | 183 | 57 | 4 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 8.84e-05 | 183 | 57 | 4 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.03e-05 | 184 | 57 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 3'|World / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-05 | 186 | 57 | 4 | e265aac37f33947ff6c83f23f8a2c63bbccd60af | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.41e-05 | 186 | 57 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.61e-05 | 187 | 57 | 4 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 9.61e-05 | 187 | 57 | 4 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 191 | 57 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Monocytes-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.04e-04 | 191 | 57 | 4 | ca0a5dc82cdef02e88fed937ca5784761896af33 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 191 | 57 | 4 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 191 | 57 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 191 | 57 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | normal_Lung-Epithelial_cells-Undetermined|Epithelial_cells / Location, Cell class and cell subclass | 1.13e-04 | 195 | 57 | 4 | 31710a593d503e46acad1db38adacace4d863388 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid|BALF-PFMC / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.15e-04 | 196 | 57 | 4 | 6361c37b0292ba9e5bf485a4809d2b0cd894c26e | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 1.15e-04 | 196 | 57 | 4 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | Megakaryocytic-erythropoietic-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.15e-04 | 196 | 57 | 4 | f90e7fe3a7b2fff30d01a25cc500876861c2e4f1 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 196 | 57 | 4 | 5fe6534af65d43eeacd4b031310242b4f706008b | |
| ToppCell | Megakaryocytic-erythropoietic-MEP-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.15e-04 | 196 | 57 | 4 | 4e97010185fa9392da8f69e7b2a7395bf063f8ff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 197 | 57 | 4 | 57dafb3047745a44b2345b8036e159c3641d496e | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-04 | 197 | 57 | 4 | 363ae03310f63a586ba3cea2a59f35d5a335a54e | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells|LPS_only / Treatment groups by lineage, cell group, cell type | 1.17e-04 | 197 | 57 | 4 | 59ddd8ff7dddf3747b988374e1a4d80959db803e | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.20e-04 | 198 | 57 | 4 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.20e-04 | 198 | 57 | 4 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.20e-04 | 198 | 57 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 198 | 57 | 4 | 623f9d64c9e800d2d7f623392bf2f22b563f0249 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.22e-04 | 199 | 57 | 4 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 199 | 57 | 4 | 7b3d4c62b11268c7c1599600d8a7b331287cf21a | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.22e-04 | 199 | 57 | 4 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.22e-04 | 199 | 57 | 4 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-TRAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.24e-04 | 200 | 57 | 4 | 7c56935446f10d202eafa1f9ee7cb0aae4c2607e | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.24e-04 | 200 | 57 | 4 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Biopsy_IPF-Immune|Biopsy_IPF / Sample group, Lineage and Cell type | 1.24e-04 | 200 | 57 | 4 | 31067dcf63030144679fca20fa41d665cb0035b7 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 200 | 57 | 4 | f19b729b03b5f225b9ed676f0ac31071a4354da3 | |
| ToppCell | severe-CD163+_Monocytes_(Sample_ID1_d7)|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-04 | 200 | 57 | 4 | 4943fe826d5fcc3dfeb8b99a7415848f3fecc994 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Pvalb_(Non-anterior_nuclei)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.89e-04 | 87 | 57 | 3 | fd0df79b02f96463a6bad90dcd019c59c8e3eb0e | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 6.87e-04 | 135 | 57 | 3 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.02e-04 | 136 | 57 | 3 | 67d736096d6b6ddb4722809557f5e987063b8d23 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.02e-04 | 136 | 57 | 3 | 47663c5d81c766a333207a44fc5b58b07309ee76 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.02e-04 | 136 | 57 | 3 | 6d2e5b871f4cf8d64e6fe0be666fb3490797c635 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.02e-04 | 136 | 57 | 3 | fd4269d194c7c11c6ab4383393a01efab05cbace | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.02e-04 | 136 | 57 | 3 | 3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.45e-04 | 145 | 57 | 3 | b17699f7f98d2361a4d26c26f52db05e7ff69dff | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.96e-04 | 148 | 57 | 3 | cb9365663f9cba35d47b5dd9079f42e88b70d915 | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 9.49e-04 | 151 | 57 | 3 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-04 | 152 | 57 | 3 | d5ba87b5d34e52cef8475befafea962d70fa8a1d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-04 | 152 | 57 | 3 | d88d68a788a3256671ebbc06e104833f1f58f07d | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-03 | 159 | 57 | 3 | 7bb76324d2026d4bd348126cb169c8411f0d7145 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 160 | 57 | 3 | 5c28121916a12dbc22ef2421040bdc9148a40b78 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 160 | 57 | 3 | b7093678987575f2f99d648821d31b4a37075aca | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Pdyn_(Neuron.Gad1Gad2.Sst-Pdyn)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.13e-03 | 39 | 57 | 2 | a24eb4c26344c5c97bbf39a1adc56ee34013dc4f | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Pdyn_(Neuron.Gad1Gad2.Sst-Pdyn)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.13e-03 | 39 | 57 | 2 | 8b5d15f979a92799a9e77f1b501d3c4fa4e8695a | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.16e-03 | 162 | 57 | 3 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.18e-03 | 163 | 57 | 3 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-03 | 163 | 57 | 3 | cab65dabeea58141c649e4fec5e0123beb3de1b3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-03 | 164 | 57 | 3 | 43045879505774ac0d9b7f760557955564f06d00 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-03 | 164 | 57 | 3 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-03 | 165 | 57 | 3 | 2477b0f1a0ea26184cf3cc4a9ffcdfa825cbc615 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.23e-03 | 165 | 57 | 3 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.23e-03 | 165 | 57 | 3 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-03 | 165 | 57 | 3 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-03 | 166 | 57 | 3 | 75d719617c61409860f298ce91cbe3a0aafa0553 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.25e-03 | 166 | 57 | 3 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-03 | 166 | 57 | 3 | c5a77a28f9819ce28828365ff31884fa2b57e032 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-03 | 167 | 57 | 3 | e85d97f8b0127663a3295db2b22b8488c0148455 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Myeloid|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-03 | 167 | 57 | 3 | ac21c7112b592e30473e693a2bbee81ff0bb0160 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-03 | 167 | 57 | 3 | a54e200789db14f41c9fc8d21cd7fa7cedde77ad | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L3-5_THEMIS_UBE2F|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-03 | 168 | 57 | 3 | bfa1491e8d433933003778b274710d3a16d973cb | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-03 | 169 | 57 | 3 | 203971cceeba150d0e8891c92662545e84c77837 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.34e-03 | 170 | 57 | 3 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-03 | 170 | 57 | 3 | 6686d1797988216c0d9417f21a2537369abce410 | |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.34e-03 | 170 | 57 | 3 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-03 | 170 | 57 | 3 | 9e94fa0d05abed3438b28296a293767096d517d6 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-03 | 171 | 57 | 3 | 8772d6349db24de47f089df2032a80345db7177f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-03 | 171 | 57 | 3 | 59d79c3e36a4930af42ebc96f05570641b9fb864 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-03 | 172 | 57 | 3 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-03 | 172 | 57 | 3 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-03 | 172 | 57 | 3 | cabe7b4131d72da87d3caacd8cced3a4f2cbef53 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-03 | 172 | 57 | 3 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-03 | 172 | 57 | 3 | 6aab59add5b180cee0ca31179c620e89d352d5c1 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-mDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-03 | 172 | 57 | 3 | cc0e2a45fa74ee19e41612c3615729462474003a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-03 | 172 | 57 | 3 | f6b4754a7e4b3e38030316a0ae00d932bfa87e41 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-03 | 172 | 57 | 3 | a125ac2db9c8ece95970a93aa6f7918d1dcef886 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-03 | 173 | 57 | 3 | 73f858f2c45d19b9ec8d99ac02c91551790f670c | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A | 7.61e-06 | 192 | 56 | 6 | 3804_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 8.31e-06 | 195 | 56 | 6 | 3721_DN | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; PC3; HT_HG-U133A | 9.60e-06 | 200 | 56 | 6 | 4598_DN | |
| Drug | AC1L4C4O | 3.55e-05 | 4 | 56 | 2 | CID000154366 | |
| Drug | GM193663 | 5.91e-05 | 5 | 56 | 2 | CID000477019 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 8.93e-05 | 184 | 56 | 5 | 2321_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 1.01e-04 | 189 | 56 | 5 | 5084_DN | |
| Drug | Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; HL60; HT_HG-U133A | 1.04e-04 | 190 | 56 | 5 | 2465_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 1.04e-04 | 190 | 56 | 5 | 4307_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.06e-04 | 191 | 56 | 5 | 4279_DN | |
| Drug | Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.06e-04 | 191 | 56 | 5 | 5434_DN | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.12e-04 | 193 | 56 | 5 | 6716_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; HL60; HG-U133A | 1.12e-04 | 193 | 56 | 5 | 1982_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; PC3; HT_HG-U133A | 1.15e-04 | 194 | 56 | 5 | 3826_DN | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.17e-04 | 195 | 56 | 5 | 3523_DN | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.17e-04 | 195 | 56 | 5 | 2929_DN | |
| Drug | Piperine [94-62-2]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.20e-04 | 196 | 56 | 5 | 3263_UP | |
| Drug | Pentoxifylline [6493-05-6]; Down 200; 14.4uM; HL60; HG-U133A | 1.20e-04 | 196 | 56 | 5 | 1444_DN | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 3797_DN | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 1528_UP | |
| Drug | Proxyphylline [603-00-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 7290_DN | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.26e-04 | 198 | 56 | 5 | 3540_DN | |
| Drug | Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.26e-04 | 198 | 56 | 5 | 6315_UP | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.26e-04 | 198 | 56 | 5 | 3793_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.29e-04 | 199 | 56 | 5 | 3786_UP | |
| Drug | Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.29e-04 | 199 | 56 | 5 | 3563_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.32e-04 | 200 | 56 | 5 | 3577_DN | |
| Disease | mean platelet volume | BBX ARID4A PAFAH1B1 RSF1 KIF16B DOCK10 SIRPB1 GNAS KYNU MSI2 NIN | 1.96e-06 | 1020 | 54 | 11 | EFO_0004584 |
| Disease | Malignant neoplasm of breast | PPP1R3A CDKN1B EEF2 BRCA2 TLL1 KIF16B GOLIM4 LSP1 MDM4 ZNF646 | 2.18e-05 | 1074 | 54 | 10 | C0006142 |
| Disease | infertility (implicated_via_orthology) | 6.86e-05 | 7 | 54 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | Pituitary Adenoma | 1.17e-04 | 9 | 54 | 2 | C0032000 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 2.95e-04 | 14 | 54 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | estrogen-receptor negative breast cancer | 3.03e-04 | 71 | 54 | 3 | EFO_1000650 | |
| Disease | lung small cell carcinoma (is_marker_for) | 3.88e-04 | 16 | 54 | 2 | DOID:5409 (is_marker_for) | |
| Disease | immature platelet count | 9.78e-04 | 106 | 54 | 3 | EFO_0803544 | |
| Disease | immature platelet fraction | 1.21e-03 | 114 | 54 | 3 | EFO_0009187 | |
| Disease | Miller Dieker syndrome | 1.29e-03 | 29 | 54 | 2 | C0265219 | |
| Disease | platelet crit | 1.68e-03 | 952 | 54 | 7 | EFO_0007985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EERRHTEAICEHEAL | 56 | Q4AC99 | |
| LKHHEDIVDEIECIE | 1411 | Q7Z7A1 | |
| TLVCHEVDLDDLDEK | 956 | P29374 | |
| EIRKEELEEDHKCSH | 391 | Q8WY36 | |
| THEEERANQIDEKEH | 131 | Q86TB3 | |
| HRDCLENGKEDLLEE | 586 | A2A2Z9 | |
| LEERTDKASHEECRE | 171 | Q96MU5 | |
| VDHEELTRDLEKHCR | 36 | P46527 | |
| HHESEDECALDLDLV | 641 | Q7L2E3 | |
| CEHDKESRLLEKHDE | 866 | Q96L93 | |
| EDVVEKVCEIHFHEI | 161 | Q96DH6 | |
| KECKAELREHEHVVE | 266 | P43034 | |
| DVREDAKEDHERTHQ | 831 | P57740 | |
| AIHEDEDENIEICSK | 1211 | Q96PY6 | |
| SEHKCIHSREDEDLI | 161 | O15151 | |
| VDRELADIHEDAKTC | 196 | Q8WXJ9 | |
| LSVHDEDRDDHTRCN | 91 | O43237 | |
| RAEELENELHHLEKE | 626 | Q3V6T2 | |
| RHDCDLLREQHEEEA | 1386 | A7E2Y1 | |
| LCHDEIENLLDSDHR | 376 | P30305 | |
| GECLKELEESHDQHA | 3861 | Q7Z6Z7 | |
| EEGCEDRILVAHDIH | 286 | Q96BW5 | |
| DVNREHDEHNEKELE | 306 | Q16821 | |
| EELKKQHSDLEEEHR | 126 | O00461 | |
| EEHQVEEEHRKALEE | 331 | O00461 | |
| DIVAKCHEEQLDHSV | 931 | Q96BY6 | |
| NKRDEEQHLESHTDC | 466 | P51587 | |
| ESTQCEDEELEHLRL | 541 | P10643 | |
| HEHEEADLELSLPEC | 86 | O95467 | |
| TDDEHENESKHEELA | 176 | Q5TB80 | |
| EDEEEAVHEQCQHER | 26 | P33241 | |
| ENVILAKIHEDEEDH | 376 | Q5VTH9 | |
| ELHLEICLKDLEEDH | 551 | P13639 | |
| HRIETDEEESCDNAH | 1301 | Q96T23 | |
| KDLNEDDHHHECLNV | 326 | Q9ULF5 | |
| HEDLLDVRNETCAKE | 1831 | P56715 | |
| DKEDTCEHKHAFELV | 501 | Q07890 | |
| VLHDNKHDCKEAECE | 761 | O43897 | |
| EEAERHKEDLEQHSR | 131 | P0C7N4 | |
| LKEAHHEATCRHEEE | 686 | Q8N4C6 | |
| EDATHLEDNECDIKL | 216 | Q9H5J8 | |
| ELKDELVRADLCENH | 86 | A6NCM1 | |
| HTEKADHEELCEFRP | 111 | Q8IUQ4 | |
| AHRDDVKLTCQVEHD | 321 | Q5TFQ8 | |
| EEERHIKRDECHIKN | 66 | A0A1B0GVM6 | |
| KCFCDEKHEIIHSEE | 101 | P17032 | |
| IEKCHHATEREEQKD | 96 | O15270 | |
| HDLQEEHIKERQELE | 556 | O15066 | |
| DQDHVCKHEEEATDI | 551 | O15015 | |
| CVDHLSRDEDEEKLV | 831 | Q7Z5K2 | |
| QEHLSEEKDERLHCE | 366 | Q6AHZ1 | |
| LEQHEKHDIEEFCFR | 121 | Q09FC8 | |
| DCADHERLLESKEEL | 101 | Q9Y6B6 | |
| ELHHLVDEEKARCLE | 181 | Q86XT4 | |
| CLHETDIHKEDHQLE | 856 | Q8IYH5 | |
| ECLEQEDLSLEDIHR | 326 | O95125 | |
| AECREELLKDDSSEH | 216 | Q9NX94 | |
| LHLDEEDKLRHFREC | 31 | Q16719 |